Abstract
Medial vascular calcification in an increasingly recognized problem in patients with diabetes and patients with chronic kidney disease. Calcification of the media is associated with significant morbidity and mortality. The phenotypic and the molecular fingerprints of medial calcification in patients with diabetes and patients with chronic kidney disease are strikingly similar. While disturbances in divalent ion homeostasis have been proposed to play a role in calcification of the media in patients with chronic kidney disease, patients with diabetes have an apparently intact bone and mineral metabolism. Chronic kidney disease as well as diabetes are now recognized as pro-inflammatory states. This review will explore the pathobiology of medial vascular calcification, review the evidence for diabetes and chronic kidney disease as pro-inflammatory states, and discuss the role of inflammation as a mechanistic link that explains the similarities in phenotypic and molecular characteristics of medial calcification in patients with chronic kidney disease and patients with diabetes mellitus.
Keywords: Vascular calcification, diabetes mellitus, chronic kidney disease, inflammation, TNF-alpha
Cardiovascular & Hematological Disorders-Drug Targets
Title: Medial Vascular Calcification in Diabetes Mellitus and Chronic Kidney Disease: The Role of Inflammation
Volume: 7 Issue: 1
Author(s): Ziyad Al-Aly
Affiliation:
Keywords: Vascular calcification, diabetes mellitus, chronic kidney disease, inflammation, TNF-alpha
Abstract: Medial vascular calcification in an increasingly recognized problem in patients with diabetes and patients with chronic kidney disease. Calcification of the media is associated with significant morbidity and mortality. The phenotypic and the molecular fingerprints of medial calcification in patients with diabetes and patients with chronic kidney disease are strikingly similar. While disturbances in divalent ion homeostasis have been proposed to play a role in calcification of the media in patients with chronic kidney disease, patients with diabetes have an apparently intact bone and mineral metabolism. Chronic kidney disease as well as diabetes are now recognized as pro-inflammatory states. This review will explore the pathobiology of medial vascular calcification, review the evidence for diabetes and chronic kidney disease as pro-inflammatory states, and discuss the role of inflammation as a mechanistic link that explains the similarities in phenotypic and molecular characteristics of medial calcification in patients with chronic kidney disease and patients with diabetes mellitus.
Export Options
About this article
Cite this article as:
Al-Aly Ziyad, Medial Vascular Calcification in Diabetes Mellitus and Chronic Kidney Disease: The Role of Inflammation, Cardiovascular & Hematological Disorders-Drug Targets 2007; 7 (1) . https://dx.doi.org/10.2174/187152907780059047
DOI https://dx.doi.org/10.2174/187152907780059047 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preface
Current Diabetes Reviews The Mechanism of Dead-in-Bed Syndrome and Other Sudden Unexplained Nocturnal Deaths
Current Diabetes Reviews Treatment Strategies for Fatty Liver Diseases
Reviews on Recent Clinical Trials Metformin Toxicity: A Report of 204 Cases from Iran.
Current Drug Safety Metabolic Syndrome and Its Effect on the Brain: Possible Mechanism
CNS & Neurological Disorders - Drug Targets Role of Statins in New-onset Diabetes Mellitus: The Underlying Cause, Mechanisms Involved, and Strategies to Combat
Current Drug Targets High-density Lipoprotein, Vascular Risk, Cancer and Infection: A Case of Quantity and Quality?
Current Medicinal Chemistry Antiplatelet Treatment in Stroke: New Insights
Current Pharmaceutical Design Hypertension in Pregnancy: Pathophysiology & Management Strategies
Current Pharmaceutical Design Development of Sol-Gel Hybrid Materials for Whole Cell Immobilization
Recent Patents on Biotechnology Cannabinoids and Schizophrenia: Therapeutic Prospects
Current Pharmaceutical Design Genetic Alterations in Differentiated Thyroid Cancers
Endocrine, Metabolic & Immune Disorders - Drug Targets Cerebral Arachidonate Cascade in Dementia: Alzheimers Disease and Vascular Dementia
Current Neuropharmacology Patent Selections
Recent Patents on Cardiovascular Drug Discovery Editorial (Hot Topic: Synthetic, Natural and Related Compounds: New Approach to Chronic Diseases Studies)
Current Topics in Medicinal Chemistry Cortisol Regulation in the Metabolic Syndrome. A Novel Therapeutic Approach
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) A Systematic Review on Pharmaceutical Diabetic Care Services in the United Arab Emirates (UAE)
Current Diabetes Reviews Extract of <i>Moringa concanensis</i> Nimmo Leaves Ameliorates Hyperglycemia and Oxidative Stress, and Improves β-cell Function in Alloxan Monohydrate Induced Diabetic Rats
Current Bioactive Compounds microRNA as Biomarkers and Regulator of Cardiovascular Development and Disease
Current Pharmaceutical Design Natural Products Modulating Autophagy Pathway Against the Pathogenesis of Diabetes Mellitus
Current Drug Targets